Lataa...
Real-World Use – Isavuconazole at a Large Academic Medical Center
BACKGROUND: Invasive fungal infections cause significant mortality and morbidity. Isavuconazole (ISV) is a new triazole approved for treatment of mucormycosis and aspergillosis. Data on its effectiveness outside clinical trials and in patients receiving prior triazole prophylaxis are lacking. METHOD...
Tallennettuna:
| Julkaisussa: | Open Forum Infect Dis |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5631743/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.028 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|